Table 4. Main complications in enrolled patients during 3-months follow up.

Main complications	Survivors (n = 42)	Non-survivors (n = 30)	P value
Hepatic encephalopathy	6 (14.3%)	14 (46.7%)	0.002
Acute kidney injury	3 (7.1%)	11 (36.7%)	0.002
Gastrointestinal hemorrhage	2 (4.8%)	6 (20%)	0.043
Intractable ascites	3 (7.1%)	17 (56.7%)	<0.001
Bacterial infection	13 (30.9%)	20 (66.7%)	0.014

Data were present as number (%)